Literature DB >> 12076756

Synthesis, cytotoxicity and antiviral activity of N,N'-bis-5-nitropyrimidyl derivatives of dispirotripiperazine.

M Schmidtke1, O Riabova, H-M Dahse, A Stelzner, V Makarov.   

Abstract

During the search for new antivirals, various N,N'-bis-5-pyrimidyl derivatives of 3,12-diaza-6,9-diazonia(5,2,5,2)dispirohexadecane dichloride (dispirotripiperazine) were synthesized. To reveal relationships between chemical structure and antiviral activity, the compounds were characterized by fast atom bombardment mass, nuclear magnetic resonance, infra red spectroscopy, and elemental analysis and examined for cytotoxicity, inhibition of cell growth and antiviral activity under in vitro conditions. The results of this study demonstrate an excellent compatibility of the test compounds for confluent as well as proliferating cells and a potent structure-dependent inhibition of herpes simplex virus type 1 replication when added during viral adsorption. Functional group analysis revealed that both the dispirotripiperazine as well as the pyrimidine ring with a nitro group in the 5 position are necessary for activity. A reduction of electron density in the terminal pyrimidine rings enhanced the antiviral activity whereas electron donor substitutions reduced it. Introduction of a methyl group in position 2 of the pyrimidine had no influence on cytotoxicity or antiviral activity.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12076756     DOI: 10.1016/s0166-3542(02)00014-1

Source DB:  PubMed          Journal:  Antiviral Res        ISSN: 0166-3542            Impact factor:   5.970


  8 in total

1.  DSTP-27 prevents entry of human cytomegalovirus.

Authors:  Rebekka Paeschke; Ina Woskobojnik; Vadim Makarov; Michaela Schmidtke; Elke Bogner
Journal:  Antimicrob Agents Chemother       Date:  2014-01-13       Impact factor: 5.191

Review 2.  Targeting heparin and heparan sulfate protein interactions.

Authors:  Ryan J Weiss; Jeffrey D Esko; Yitzhak Tor
Journal:  Org Biomol Chem       Date:  2017-06-27       Impact factor: 3.876

3.  Multiple heparan sulfate binding site engagements are required for the infectious entry of human papillomavirus type 16.

Authors:  Kathleen F Richards; Malgorzata Bienkowska-Haba; Jhimli Dasgupta; Xiaojiang S Chen; Martin Sapp
Journal:  J Virol       Date:  2013-08-21       Impact factor: 5.103

4.  Heparan sulfates and coxsackievirus-adenovirus receptor: each one mediates coxsackievirus B3 PD infection.

Authors:  A E Zautner; U Körner; A Henke; C Badorff; M Schmidtke
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

5.  Inhibition of transfer to secondary receptors by heparan sulfate-binding drug or antibody induces noninfectious uptake of human papillomavirus.

Authors:  Hans-Christoph Selinka; Luise Florin; Hetal D Patel; Kirsten Freitag; Michaela Schmidtke; Vadim A Makarov; Martin Sapp
Journal:  J Virol       Date:  2007-08-08       Impact factor: 5.103

6.  Diazadispiroalkane Derivatives Are New Viral Entry Inhibitors.

Authors:  Vadim Makarov; Elke Bogner; Rebekka Adfeldt; Janna Schmitz; Barbara Kropff; Marco Thomas; Natalia Monakhova; Julia E Hölper; Barbara G Klupp; Thomas C Mettenleiter
Journal:  Antimicrob Agents Chemother       Date:  2021-03-18       Impact factor: 5.191

7.  PDSTP Is the First Drug in Class to Treat Coronavirus Infection.

Authors:  V A Makarov; V O Popov
Journal:  Her Russ Acad Sci       Date:  2022-09-06       Impact factor: 0.552

8.  Human papillomavirus species-specific interaction with the basement membrane-resident non-heparan sulfate receptor.

Authors:  Kathleen F Richards; Santanu Mukherjee; Malgorzata Bienkowska-Haba; Jia Pang; Martin Sapp
Journal:  Viruses       Date:  2014-12-05       Impact factor: 5.048

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.